No. 2198 July 26, 2010
PHARMA JAPAN is a must read for every busy executive who needs to keep up with the world's second largest health care market.
P. Reed Maurer
 　　　　　　　　　　　　
Nippon Chemiphar Aims at Sales of ¥30.0 Bil. with Generics in FY2012
 p 1
Drug Market in Japan to Grow 3-6% in 2010-2014: IMS Japan
 p 2
Pariet to See Generics from 23 Companies in Nov. p 5
Celgene's 2 Drugs for Multiple Myeloma Recommended for Approval p 6
All Candidates from Nichiiren Fail to Obtain Seat in Upper Housep 7
Terumo Aims at Sales of ¥1 Tril. within 10 Years: New President Shintaku p 12
Pfizer Signs Clinical Trial Partnership Agreement with NHO p 14
Kobayashi to Develop More Class 1 OTC Drugs p 17
Erbitux Associated with Fewer Severe Infusion Reactions in Japan p 18

PHARMA JAPAN witnesses important events taking place in the second-largest pharmaceutical market on a comprehensive, weekly basis.



│Information│Order Here│Preview│Ads│Table of Contents│Books│